A Clinical Study of Allogenic CD19-CAR-T in the Treatment of R/R B-Cell Hematologic Malignancies

Clinical trial NCT07316907 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07316907
Sponsor: YANRU WANG
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Hematologic Malignancies Lymphoma

Start date: 2025-12-22
Primary completion: 2027-06-30
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.